Obesity ETF (SLIM) Short Interest Ratio & Short Volume

Short interest is the volume of Obesity ETF shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 100 shares of SLIM short. Learn More on Obesity ETF's current short interest.

Obesity ETF saw a decline in short interest in February. As of February 28th, there was short interest totaling 100 shares, a decline of 85.7% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Obesity ETF: First Trust Nasdaq Pharmaceuticals ETF (1.13%), JPMorgan Healthcare Leaders ETF (0.07%), ProShares UltraShort Nasdaq Biotechnology (4.12%), Invesco Nasdaq Biotechnology ETF (0.32%), ProShares Ultra Nasdaq Biotechnology (0.57%), Invesco Dorsey Wright Healthcare Momentum ETF (0.25%), VanEck Biotech ETF (0.18%), VanEck Pharmaceutical ETF (41.19%), and iShares Biotechnology ETF (29.39%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.18 billion), Microchip Technology Incorporated ($2.36 billion), McKesson Corporation ($2.18 billion), Tiffany & Co. ($1.90 billion), The Charles Schwab Corporation ($1.85 billion), Match Group Inc. ($1.60 billion), Hormel Foods Corporation ($1.59 billion), The Clorox Company ($1.52 billion), eBay Inc. ($1.45 billion), and Lumen Technologies, Inc. ($1.30 billion). View all of the most shorted stocks.

Short selling SLIM is an investing strategy that aims to generate trading profit from Obesity ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Obesity ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLIM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLIM, twice per month. The most recent reporting period available is February, 28 2020.